Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Congenital adrenal hyperplasia].

Problemy endokrinologii·2026
Same author

[Modern capabilities of contrast-enhanced computed tomography in the diagnosis of adrenal adenomas].

Problemy endokrinologii·2026
Same author

[The role of microchimerism in the development of endocrine diseases (using autoimmune thyroid diseases and type 1 diabetes mellitus as examples)].

Problemy endokrinologii·2026
Same author

[The opportunities to improve therapy adherence in patients with overweight and obesity in real clinical practice].

Problemy endokrinologii·2026
Same author

The assessment of iodine sufficiency in women in the first trimester of pregnancy living in areas of the Voronezh region with varying levels of iodine consumption.

Problemy endokrinologii·2026
Same author

[A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide].

Problemy endokrinologii·2026

Related Experiment Video

Updated: May 15, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

[Graves' disease and pregnancy].

M V Altashina, E A Troshina, N Yu Sviridenko

    Klinicheskaia Meditsina
    |January 5, 2013
    PubMed
    Summary

    Graves' disease, a common cause of thyrotoxicosis, often requires radical treatment. Careful management is crucial for women with Graves' disease planning pregnancy due to high complication risks.

    Area of Science:

    • Endocrinology
    • Reproductive Medicine

    Background:

    • Thyrotoxicosis, excess thyroid hormones, is frequently caused by Graves' disease in young to middle-aged adults.
    • Conservative thyrostatic medication is the primary treatment, but 70% of cases necessitate radical intervention.
    • Graves' disease before pregnancy poses significant risks, including miscarriage and complications, contraindicating pregnancy without careful management.

    Observation:

    • A 27-year-old patient with Graves' disease planned pregnancy but underwent prolonged, unnecessary conservative therapy.
    • The case highlights the critical need for appropriate treatment selection in women of reproductive age.

    Findings:

    • Delayed or inappropriate treatment of thyrotoxicosis can complicate pregnancy planning.
    • Radical treatment may be indicated in a majority of Graves' disease cases for long-term management.

    More Related Videos

    Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
    07:51

    Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

    Published on: May 21, 2015

    Related Experiment Videos

    Last Updated: May 15, 2026

    Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
    04:39

    Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

    Published on: March 17, 2023

    Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
    07:51

    Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

    Published on: May 21, 2015

  • Effective management strategies for thyrotoxicosis during and after pregnancy are essential.

    • Implications:

    • Optimizing treatment for Graves' disease is vital for women desiring pregnancy.
    • Early consideration of radical treatment options can improve outcomes.
    • Further research into managing thyrotoxicosis in pregnant patients is warranted.